Floatz logo

Therapeutic Asset Ratings

17,289 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
DOXORUBICIN
Breast Neoplasm
Merck Sharp & Dohme LLCP4BB (70)
DOXORUBICIN
Primary Central Nervous System Lymphoma
Juan P. Alderuccio, MDP4BB (70)
DOXORUBICIN
Hepatocellular Carcinoma
VA Office of Research and DevelopmentP4BB (70)
DOXORUBICIN
Hodgkins Lymphoma
M.D. Anderson Cancer CenterP4BB (70)
DOXORUBICIN
Mantle Cell Lymphoma
National Cancer Institute (NCI)P4BB (70)
DOXORUBICIN
Plasma Cell Myeloma
GlaxoSmithKlineP4BB (70)
Edoxaban
Ischemic Stroke
Sunnybrook Health Sciences CentreP4BB (70)
Edoxaban
Stroke Disorder
Ewha Womans University Seoul HospitalP4BB (70)
Entecavir
Fibrotic Liver Disease
Tanta UniversityP4BB (70)
Escitalopram
Dementia
Ohio State UniversityP4BB (70)
Escitalopram
Schizophrenia
Minerva NeurosciencesP4BB (70)
ETOPOSIDE
Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer CenterP4BB (70)
ETOPOSIDE
Extranodal Nasal NK/T Cell Lymphoma
Tarapeutics Science Inc.P4BB (70)
ETOPOSIDE
ALK-Negative Anaplastic Large Cell Lymphoma
City of Hope Medical CenterP4BB (70)
ETOPOSIDE
ALK-Positive Anaplastic Large Cell Lymphoma
Mingzhi ZhangP4BB (70)
ETOPOSIDE
Angioimmunoblastic T-Cell Lymphoma
Eric Jacobsen, MDP4BB (70)
ETOPOSIDE
Lymphoma
Memorial Sloan Kettering Cancer CenterP4BB (70)
ETOPOSIDE
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
Alliance for Clinical Trials in OncologyP4BB (70)
EXEMESTANE
Breast Neoplasm
Fujian Cancer HospitalP4BB (70)
FENTANYL
Post-Operative Pain, Non-Human Animal
IVO JURISICP4BB (70)
Fingolimod
Multiple Sclerosis
BiogenP4BB (70)
Fludarabine
Acute Lymphoblastic Leukemia
Sawa Ito, MDP4BB (70)
Fludarabine
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
French Innovative Leukemia OrganisationP4BB (70)
Fludarabine
Lymphoma
National Cancer Institute (NCI)P4BB (70)
Fludarabine
Myelodysplastic Syndrome
City of Hope Medical CenterP4BB (70)
Showing 926 to 950 of 17,289 assets
PreviousPage 38 of 692Next